Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 11 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 11964016

    Combination of IL-4/IL-13 pathway inhibitors and plasma cell ablation for treating allergy

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  2. US 11958849

    GLS1 inhibitors for treating disease

    The Board of Regents of the University of Texas System · Granted Apr 16, 2024 · Expires Apr 11, 2044

    granted
  3. US 11957704

    Methods of treating metabolic disorders and cardiovascular disease with inhibin subunit beta E (INHBE) inhibitors

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 16, 2024 · Expires Apr 11, 2044

    granted
  4. US 11957677

    Cancer treatment using FGFR inhibitors and PLK1 inhibitors

    Cardiff Oncology, Inc. · Granted Apr 16, 2024 · Expires Apr 11, 2044

    granted
  5. US 11952364

    TRK inhibitors useful as anticancer drugs

    TYLIGAND BIOSCIENCE (SHANGHAI) LIMITED · Granted Apr 9, 2024 · Expires Apr 4, 2044

    granted
  6. US 11952366

    Substituted 1,3,5-triazines as inhibitors for a rho family of GTP-ases

    The Regents of the University of California · Granted Apr 9, 2024 · Expires Apr 4, 2044

    granted
  7. US 11951100

    Formulations of RBP4 inhibitors and methods of use

    Belite Bio, Inc · Granted Apr 9, 2024 · Expires Apr 4, 2044

    granted
  8. US 11952352

    Ras inhibitors

    Revolution Medicines, Inc. · Granted Apr 9, 2024 · Expires Apr 4, 2044

    granted
  9. US 11952389

    Benzodiazepine derivatives as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Apr 9, 2024 · Expires Apr 4, 2044

    granted
  10. US 11952376

    Substituted amino acids as integrin inhibitors

    Pliant Therapeutics, Inc. · Granted Apr 9, 2024 · Expires Apr 4, 2044

    granted
  11. US 11945822

    Pyrazolo-triazine and/or pyrazolo-pxrimidine derivatives as selective inhibitor of cyclin dependent kinase

    Lead Discovery Center GmbH · Granted Apr 2, 2024 · Expires Mar 28, 2044

    granted
  12. US 11944626

    Small molecule inhibitors of ALDH and uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 2, 2024 · Expires Mar 28, 2044

    granted
  13. US 11944614

    Imidazo[4,5-c]pyridine compounds as LSD-1 inhibitors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 2, 2024 · Expires Mar 28, 2044

    granted
  14. US 11938134

    Metalloenzyme inhibitor compounds

    Eikonizo Therapeutics, Inc. · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  15. US 11939340

    CDK inhibitors and their use as pharmaceuticals

    Prelude Therapeutics, Incorporated · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  16. US 11939361

    Compositions of peptide inhibitors of Interleukin-23 receptor

    Protagonist Therapeutics, Inc. · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  17. US 11931402

    Compositions for treating heart disease by inhibiting the action of mAKAP-β

    Anchored RSK3 Inhibitors, LLC · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted
  18. US 11932692

    Methods of treating cancer pain by administering a PD-1 inhibitor

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted
  19. US 11932633

    KRas G12C inhibitors

    Mirati Therapeutics, Inc. · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted
  20. US 11931343

    CD73 inhibitors

    Arcus Biosciences, Inc. · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted
  21. US 11926826

    Twist signaling inhibitor compositions and methods of using the same

    The Regents of the University of California · Granted Mar 12, 2024 · Expires Mar 7, 2044

    granted
  22. US 11925629

    Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer

    Asana BioSciences, LLC · Granted Mar 12, 2024 · Expires Mar 7, 2044

    granted
  23. US 11919888

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  24. US 11918560

    Serine protease inhibitor for treating coronavirus infection

    RedHill Biopharma Ltd. · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted